Jan 28, 2026
Wuxi, China,Jan. 28, 2026(GLOBE NEWSWIRE) --Park Ha Biological Technology Co., Ltd.(NASDAQ: BYAH) (the “Company”) today announced the closing of a best-efforts follow-on public offering of 21,875,000 units (each a “Unit”) at an offering price ofUS$0.11
Jan 27, 2026
Wuxi, China, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH) (the “Company”) today announced the pricing of a best-efforts follow-on public offering of 21,875,000 units (each a “Unit”) at an offering price of US$0.112 per Unit.&nbs
Oct 24, 2025
Wuxi, China,Oct. 24, 2025(GLOBE NEWSWIRE) --Park Ha Biological Technology Co., Ltd.(NASDAQ: PHH; the “Company” or “PHH”) announced that the Company will be changing its ticker symbol from “PHH” to “BYAH”. Effective onTuesday October 28, 2025, the Company’s ordi
Dec 30, 2024
Wuxi, China, Dec. 30, 2024 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd. (Nasdaq: PHH) (the “Company”), a company focused on developing private skincare labels, direct skincare product sales, and franchise alliance promotions, today announced the closing of its initial pu
Dec 26, 2024
Wuxi, China, Dec. 26, 2024 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd. (the "Company"), a company focused on developing private skincare labels, direct skincare product sales, and franchise alliance promotions, today announced the pricing of its initial public o